Abstract Regular exercise improves the risk of arterial stiffness by improving arterial endothelial function and regulating smooth muscle tone and proliferation. However, individual responses to exercise training can vary. Gene polymorphism, namely individual differences in the DNA sequence, is a main causal factor of phenotypic variation in adaptations of physiological function and morphology to regular exercise. In the abdominal aorta of aerobically trained rats, more than 300 genes were detected with differential expression. Additionally, many candidate gene polymorphisms, associated with the risk of arterial stiffening, have been identified. Therefore, various vasodilation and vasoconstriction-related gene polymorphisms may be associated with individual variation in the effects of physical exercise and cardiorespiratory fitness on arterial stiffness risks. Recently, several studies reported that gene polymorphisms, such as atrial natriuretic peptide, endothelial nitric oxide synthase, estrogen receptor-α, endothelin receptor-A, endothelin receptor-B, angiotensinogen, angiotensin-converting enzyme, methylenetetrahydrofolate reductase and fatty acid binding protein 2, were associated with individual variation in the effects of physical exercise or cardiorespiratory fitness on arterial stiffness risks. This article reviews the recent findings on genetic factors influencing the effects of exercise on the risk of cardiovascular diseases, i.e., arterial stiffness.
Introduction
Approximately 26% of the annual death rate in Japan is caused by arteriosclerotic and/or atherosclerotic disorders, including cardiovascular and cerebrovascular diseases, the second and fourth leading causes of mortality, respectively. Therefore, the prevention and improvement of arterial stiffening, as a causal factor of arteriosclerosis and atherosclerosis, is an important issue. Regular exercise improves the risk of arterial stiffness by improving arterial endothelial function and regulating smooth muscle tone and proliferation 1) . However, individual responses to exercise training can vary. The natural question, therefore, arises as to whether individual variations of regular exercise-related reduction in arterial stiffness can be partly attributed to genetic factors, such as gene polymorphisms. This article reviews the recent findings on genetic factors influencing the effects of exercise on the risk of cardiovascular diseases, i.e., arterial stiffness.
Arterial function
The wall of an artery constitutes 3 layers: the intima, media, and adventitial membranes. The key components of the three layers are endothelial cells, smooth muscle cells, and fibroblasts, respectively. The aorta and large arteries (i.e., central arteries) are conduits delivering blood to the tissues and organs, and the central arteries act as mechanical buffers to normalize fluctuations in blood pressure created by cardiac pulsation and intermittent blood flow. Increased arterial stiffness impairs this buffering function, leading to increases in systolic blood pressure (SBP) and left ventricular afterload. Arterial stiffness may be an independent risk factor for mortality and cardiovascular disorder 2, 3) . The smooth muscle in the media membrane regulates the vascular tonus. Regulation of the vascular tonus by the smooth muscle is by both autonomic and vasoactive humoral factors. Furthermore, the autocrine and paracrine secretions of vasoregulatory substances, i.e., vasodilator and vasoconstrictor substances released from endothelial cells, related to the vascular tonus. The secretion of some endothelium-derived vasodilators and vasoconstrictors is regulated by stimulation of autonomic and humoral factors, blood flow-induced shear-stress, and endocrine hormones 1) . Thus, the causal factor of arterial stiffening is associated with complex mechanisms. Correspondence: iemitsu@fc.ritsumei.ac.jp
Molecular mechanism of exercise-induced adaptation
In the arteries, exercise training-induced improvement of endothelial function, such as a change in endothelialderived peptide and protein production, ameliorates arterial stiffness 4, 5) . Moreover, exercise training induces enlargement of the lomenta area in the artery 6, 7) . These exercise training-induced adaptations have preventive and treatment effects for arterial stiffening. However, the underlying molecular mechanisms of these exercise training-induced improvements remain unclear. Recently, concerning the underlying molecular mechanisms involved in the improvement of arterial stiffness by aerobic exercise, several studies have reported changes in the gene expression of endothelium-derived vasodilators and vasoconstrictors.
In our study using exercise-trained rats, with a significantly lower carotid-femoral pulse wave velocity (cfPWV) than controls, the expression levels of 3800 genes in the abdominal aorta were determined using microarray analysis 8) . There were 323 genes with different expression levels (206 genes upregulated and 117 genes downregulated), including 29 (24 upregulated and 5 downregulated) genes identified as potential candidates involved in vasodilation and arterial destiffening. In particular, exercise-trained rats had significantly higher gene expression of endothelial nitric oxide synthase (eNOS), C-type natriuretic peptide (CNP), prostaglandin E-prostanoid 2 receptor (PGE-EP2R), and prostaglandin EP4 receptor (PGE-EP4R), which are known vasodilators synthesized by endothelial cells (Fig. 1) . Furthermore, after 8 weeks of swimming-exercise training, the aorta in aged male rats showed significantly higher levels of eNOS mRNA expression than that in age-matched sedentary controls 9) . Therefore, the underlying molecular mechanism of aerobic training-induced decreases in arterial stiffness and increased endothelium-dependent vasodilation may contribute to altered gene expression of eNOS, CNP, PGE, and other endothelium-derived mediators in the arteries. However, further study is needed to examine other molecules, because exercise training causes changes in gene expression in the trained artery.
Gene polymorphisms
Deoxyribonucleic acid (DNA) is a molecule that encodes the genetic instructions used in the development and functioning of all tissue in humans. Genetic information is encoded as a sequence of nucleotides (guanine, adenine, thymine, and cytosine) recorded using the letters G, A, T, and C. DNA normally exists in the form of doublestranded helices, in which A bonds only to T and G bonds only to C. In the first step, the information in DNA is transferred to a messenger RNA (mRNA) molecule by way of a process called transcription. Each group of three base pairs in mRNA constitutes a codon, and each codon specifies a particular amino acid. Therefore, individual differences in the DNA sequence may lead to phenotypic 8) . JPFSM : Exercise, arterial stiffness, and gene polymorphism variation in physiological function and morphology. Genetic variation, termed gene polymorphism, is a main causal factor in the development of individual differences. The human genome has 99.9% similarity and 0.1% variation. It follows that one variation occurs in every 1000 base pairs of the DNA sequence. Since there are about 3 billion base pairs in the human genome, approximately 3 million bases are variable. The genetic variation accounts for individual differences in physiological features such as skin, eye, and hair color; predisposition to obesity; disease morbidity; and drug response. Gene polymorphism is defined as changes found at a frequency of 1% or higher in the population. Gene polymorphisms exist in several forms, such as single nucleotide polymorphisms (SNPs), insertions, deletions, variable number tandem repeats (VNTRs), and copy number variations (CNVs).
In the year 2001, the draft sequence and initial analysis of the human genome were published in Nature 10) and Science 11) . After two years, the Human Genome Project was declared complete in April 2003. Additionally, in 2000, the Japanese Millennium Genome Project was investigated to explore SNPs and other genetic variations in Japanese individuals. Consequently, 174,269 genetic variations were identified by 2002, and the results released as the Genomic database (http://snp.ims.u-tokyo.ac.jp) 12) . The genetic information is utilized to investigate and develop tailor-made medicine: gene-based diagnosis and an individualized approach to the selection of treatment 13) . In the area of health and sports science, previous studies were examined to identify gene polymorphisms that influence physical performance and the effects of exercise.
Gene polymorphisms associated with arterial stiffness
Many candidate gene polymorphisms associated with the risk of arterial stiffening have been identified. One commonly used technique to identify genetic risk factors for cardiovascular disease is the candidate gene approach, which directly tests the effects of genetic variants of a potentially contributing gene in an association study. Additionally, a genome-wide association study is an approach that involves rapidly scanning markers across complete sets of DNA, or genomes, of many people to find genetic variations associated with a particular disease. Once new genetic associations are identified, researchers can use the information to develop better strategies to detect, treat and prevent the disease. By using the genome-wide scan approach, quantitative trait loci (QTLs) influencing the risk of arterial stiffness are identified using SNP maps of the human genome 14) . Many candidate gene polymorphisms have been identified from QTLs associated with the risk of arterial stiffness. A list of reported candidate gene polymorphisms is showed in Table 1 15-41) . Typical candidate genes include genes involved in the renin-angiotensin system, natriuretic peptides, eNOS, sympathetic β receptors, adhesion molecules, and interleukin-6 .
Gene polymorphisms influencing the effects of physical activity and cardiorespiratory fitness
Recent studies suggest that gene polymorphisms are associated with individual variation in the effects of physical exercise and cardiorespiratory fitness on arterial stiffness risk. We examined the difference in physical activity-induced improvement in brachial-ankle arterial pulse wave velocity (baPWV) associated with a valineto-methionine polymorphism (V32M: 664G>A) in exon 1 of the atrial natriuretic peptide (ANP) gene, which relates to vasodilation 42) . Subjects with the GG genotype of ANP showed exercise-dependent improvements, whereas subjects with the GA or AA genotype did not change (Fig.  2) . Thus, this study indicated that an SNP can alter the effect of relationship between physical activity and arterial stiffness. Kimura et al. 43) investigated the relationship between the 27-base pair tandem repeat polymorphism in intron 4 of the eNOS gene (eNOS 4a/b) and resting systolic blood pressure. This study showed no significant correlation between genotype and blood pressure. However, when subjects were divided into 3 groups based on the level of physical activity, systolic blood pressure in the low physical activity group with the a allele (aa or ba genotype) was significantly higher than those with the bb genotype 43) . Thus, regular exercise may be needed to cancel the genetic negative effects of gene polymorphisms, which are associated with the risk of arterial stiffness. Furthermore, in our cross-sectional study of healthy postmenopausal women, the effect of daily physical activity on arterial stiffness was compared based on the SNP at -401T/C of intron 1 of the estrogen receptor (ER)-α gene, which regulates the endothelium-derived vasodilator eNOS 44) . A significant reduction in baPWV associated with high daily energy expenditure was observed in individuals with the TC and CC genotypes, but not those with the TT genotype in the ER-α gene (Fig. 3) . The association between the -401T>C polymorphism and habitual exercise-induced changes in arterial stiffness was observed in females, whereas this association did not show in males 37, 44) . Therefore, the effect of gene polymorphism on the improvement of arterial stiffness, in response to habitual exercise, may differ with genders.
Additionally, we investigated the association between an exercise-induced reduction in arterial stiffness and SNPs in endothelin-1 (ET-1) receptor genes in regulating vasoconstriction: 958A>G in exon 6 of endothelin receptor A (ET-A) and 831A>G in exon 4 of endothelin receptor B (ET-B) 45) . A physical activity-induced decrease in arterial stiffness was observed in individuals with the AA genotype at 958A>G of ET-A and those with the AG and GG genotypes at 831A>G of ET-B, but not in individuals with other genotypes 45) . In genes of angiotensinogen (AGT) and angiotensinconverting enzyme (ACE), involved in the renin-angiotensin vasoconstrictor system, several studies reported the relationship between these gene polymorphisms and blood pressure responses to regular exercise. In a 6-year randomized controlled study that evaluated the significance of the AGT Met235Thr polymorphism, moderate intensity exercise attenuated an aging-induced increase in blood pressure in Met homozygotes, but did not affect other genotypes 46) . However, in the study of 476 subjects, who carried out a 20-week endurance training program, neither baseline values nor training responses in resting blood pressure were associated with AGT Met235Thr genotypes 47) . Additionally, in ACE gene insertion (I) and deletion (D) polymorphisms, the Japanese patients with mild to moderate essential hypertension and II or ID genotypes, showed greater decreases in systolic and diastolic blood pressure in response to aerobic exercise training for 10 weeks than patients with the DD genotype 48) . On the other hand, in another study using Caucasian men and women, the ACE I/D genotypes were not associated with an alteration in resting blood pressure following 20 weeks of aerobic exercise training 47) . However, male and female subjects with the ACE DD genotype showed a greater reduction in blood pressure response measured during submaximal exercise at 50 W than subjects with II or ID genotypes. Therefore, several gene polymorphisms may be associated with individual variation in the effects of exercise training on arterial stiffness risks at basal levels and during exercise-stimulated responses.
Recently, we reported the effects of cardiorespiratory fitness on the relationship between arterial stiffness and gene polymorphism in methylenetetrahydrofolate reductase (MTHFR), an enzyme involved in the metabolism of homocysteine in healthy Japanese subjects 49) . Concerning the TT genotype in individuals homozygous for the T (Val) allele of the MTHFR C677T polymorphism (Ala222Val), a relative deficiency in the remethylation process of homocysteine into methionine leads to mildto-moderate hyperhomocysteinemia, a condition recognized as an independent risk factor for arterial stiffness and atherosclerosis. In our recent study, subjects were divided into groups with high (High-Fit) and low cardiorespiratory fitness (Low-Fit) based on the median value of peak oxygen uptake in each gender and decade 49) . In the Low-Fit subjects, carotid β-stiffness was significantly higher in TT genotype individuals than that in CC and CT genotypes. However, no such differences were observed in High-Fit subjects (Fig. 4) protein 2 (FABP2) Ala54Thr polymorphism is a candidate gene associated with the risk of cardiovascular disease 50) . In the Low-Fit group, carotid β-stiffness, systolic blood pressure, and diastolic blood pressure were higher for individuals with the Ala/Ala genotype compared with those with the Ala/Thr or Thr/Thr genotype, whereas no differences were observed in the High-Fit group. Thus, regular exercise may be needed to cancel the genetic negative effects of gene polymorphisms, which are associated with the risk of arterial stiffness.
Thus, these findings suggest that gene polymorphisms are associated with individual variation in the effects of physical exercise and cardiorespiratory fitness on arterial stiffness risks. As an underlying mechanism of these previous observations, it is speculated that exercise training induces improvement of endothelial function via another compensatory mechanism. However, the mechanism underlying the combined effects of cardiorespiratory fitness or physical activity and gene polymorphisms on arterial stiffness remains unclear. Additionally, it has been reported that not only gene polymorphisms in ANP, ER-α, ET-A, ET-B, eNOS, AGT, ACE, MTHFR, FABP2, but other gene polymorphisms, i.e., ET-1, angiotensin II receptor type-1, guanine nucleotide-binding protein β-3, G-protein coupled receptor, and transforming growth factor β-1, are associated with individual variation in the effects of physical exercise and cardiorespiratory fitness on arterial stiffness risks.
In the abdominal aorta of aerobically trained rats, more than 300 genes were detected with differential expression, including those encoding CNP, PGE, and other molecules known to have vasoregulatory effects 8) . Therefore, various vasodilators and vasoconstrictors contribute to the underlying molecular mechanism of exercise training-induced decreases in arterial stiffness. These findings suggest that a variety of gene polymorphisms may be associated with individual variation in the effects of physical exercise and cardiorespiratory fitness on arterial stiffness risks. Thus, further study is needed in examining the genome-wide scan approach to identifying gene polymorphisms that are associated with the effects of exercise training.
